InMed Pharmaceuticals, Inc. (INM)
1.59
0.00 (0.00%)
USD |
NASDAQ |
Oct 27, 16:00
1.58
-0.01
(-0.63%)
After-Hours: 20:00
InMed Pharmaceuticals Cash from Operations (Quarterly) : -2.909M for June 30, 2026
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -2.909M |
| March 31, 2026 | -1.759M |
| December 31, 2025 | -2.352M |
| September 30, 2025 | -1.608M |
| June 30, 2025 | -2.322M |
| March 31, 2025 | -1.562M |
| December 31, 2024 | -2.448M |
| September 30, 2024 | -1.827M |
| June 30, 2024 | -0.9629M |
| March 31, 2024 | -1.964M |
| December 31, 2023 | -1.817M |
| September 30, 2023 | -2.174M |
| June 30, 2023 | -0.7367M |
| March 31, 2023 | -1.655M |
| December 31, 2022 | -2.618M |
| September 30, 2022 | -2.256M |
| June 30, 2022 | -3.989M |
| March 31, 2022 | -5.274M |
| December 31, 2021 | -3.532M |
| September 30, 2021 | -2.654M |
| June 30, 2021 | -2.198M |
| March 31, 2021 | -5.598M |
| December 31, 2020 | -1.063M |
| September 30, 2020 | -1.372M |
| June 30, 2020 | -1.244M |
| Date | Value |
|---|---|
| March 31, 2020 | -1.471M |
| December 31, 2019 | -2.066M |
| September 30, 2019 | -2.365M |
| June 30, 2019 | -1.768M |
| March 31, 2019 | -2.077M |
| December 31, 2018 | -1.391M |
| September 30, 2018 | -1.317M |
| June 30, 2018 | -1.006M |
| March 31, 2018 | -0.7516M |
| December 31, 2017 | -0.7844M |
| September 30, 2017 | -1.077M |
| June 30, 2017 | -0.7351M |
| March 31, 2017 | -0.7428M |
| December 31, 2016 | -0.6437M |
| September 30, 2016 | -0.1663M |
| June 30, 2016 | -0.1126M |
| March 31, 2016 | -0.0349M |
| December 31, 2015 | -0.1092M |
| September 30, 2015 | -0.1307M |
| June 30, 2015 | -0.7565M |
| March 31, 2015 | -0.6728M |
| December 31, 2014 | -0.0881M |
| September 30, 2014 | -0.1053M |
| June 30, 2014 | -0.6248M |
| March 31, 2014 | 0.0006M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Quarterly) Benchmarks
| NervGen Pharma Corp. | -4.086M |
| Milestone Pharmaceuticals, Inc. | -22.53M |
| Appili Therapeutics, Inc. | -0.0267M |
| Clearmind Medicine, Inc. | -1.859M |
| Lexaria Bioscience Corp. | -1.635M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Financing (Quarterly) | -0.0008M |
| Free Cash Flow | -8.628M |
| Free Cash Flow Per Share (Quarterly) | -0.6653 |
| Free Cash Flow to Equity (Quarterly) | -2.489M |
| Free Cash Flow to Firm (Quarterly) | -2.899M |
| Free Cash Flow Yield | -132.9% |